StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

GRI Bio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

GRI Bio's enterprise value was -$6.95M on Nov 11, 2026, against $179.02M a year earlier. Over the last 5 years it ranged from -$8.86M to $311.63B, with a median of $1.63B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$6.95M-137.5%
2025Dec 31, 2025$18.54M-99.1%
2024Dec 31, 2024$1.98B-71.9%
2023Dec 29, 2023$7.04B-69.2%
2022Dec 30, 2022$22.85B-90.9%
2021Dec 31, 2021$252.17B–

More GRI Bio figures

See a number that looks wrong?